Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-000978
Filing Date
2025-02-11
Accepted
2025-02-11 09:12:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5364
  Complete submission text file 0001085146-25-000978.txt   7407
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Subject) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-80415 | Film No.: 25607880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE FINANCIAL CENTER 23RD FLOOR BOSTON MA 02111
Business Address ONE FINANCIAL CENTER 23RD FLOOR BOSTON MA 02111 6174287100
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by) CIK: 0001177719 (see all company filings)

EIN.: 800175963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A